Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 95 of 509 for:    ASPIRIN AND P2

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03718429
Recruitment Status : Recruiting
First Posted : October 24, 2018
Last Update Posted : February 6, 2019
Janssen Scientific Affairs, LLC
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : December 2020